DRD/II 24 G/R S/R + 69 Table

lt;p><strong style="font-family: arial, helvetica, sans-serif; font-size: medium;">Steel Gear Reduction -</strong><span style="font-family: arial, helvetica, sans-serif; font-size: medium;"> Bailey uses only steel gears in their
Steel Gear Reduction - Bailey uses only steel gears in their heavy-duty slab rollers for strength and durability: never nylon or plastic. Gear reduced for extra easy operation.  34 Dia. Round Handle - The large diameter handle provides ample leverage for easy rolling. Reverse-Threaded Handle Adapter - Standard on all gear-reduced machines, this special design prevents damage to the slab roller if it is rolled in the wrong direction. Simultaneous Height Adjustment - Top Roller is adjusted from one side only. Rollers always remain parallel for consistently even clay slabs. One-Pass Slab Rolling - Bailey's unique Bi-Level Table features a lower feed counter that increases the surface contact between the bottom roller and the clay canvas for better grip and compression. Allows you to roll up to 2 of soft wedgable clay into a slab in one pass.

Global, regional, and national burden of spinal cord injury, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet Neurology

Ergotron – WorkFit-D Standing Desk, Height Adjustable Sit Stand Ergonomic Desk – Birch : Office Products

EZH2 inhibitor tazemetostat in patients with relapsed or refractory, BAP1-inactivated malignant pleural mesothelioma: a multicentre, open-label, phase 2 study - The Lancet Oncology

Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults - eBioMedicine

A Comparison of Glyburide and Insulin in Women with Gestational Diabetes Mellitus

Pituitary-Tumor Endocrinopathies

Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials - The Lancet

DRD/II 24 Direct Drive S/R + 69 inch Table

Safety and immunogenicity following a homologous booster dose of a SARS-CoV- 2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial - The Lancet Infectious Diseases

Naltrexone 6 mg once daily versus placebo in women with fibromyalgia: a randomised, double-blind, placebo-controlled trial - The Lancet Rheumatology

Spatial structure impacts adaptive therapy by shaping intra-tumoral competition

Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial - The Lancet Oncology

Climate-sensitive health counselling: a scoping review and conceptual framework - The Lancet Planetary Health

Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial - The Lancet Haematology